Advisors Asset Management Inc. Has $4.87 Million Position in The Clorox Company (NYSE:CLX)

Advisors Asset Management Inc. increased its holdings in shares of The Clorox Company (NYSE:CLX) by 43.4% during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 29,865 shares of the company’s stock after acquiring an additional 9,037 shares during the period. Advisors Asset Management Inc.’s holdings in Clorox were worth $4,865,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in CLX. Mizuho Securities USA LLC lifted its holdings in Clorox by 46,877.8% during the 3rd quarter. Mizuho Securities USA LLC now owns 4,500,000 shares of the company’s stock valued at $733,095,000 after purchasing an additional 4,490,421 shares during the last quarter. Van ECK Associates Corp lifted its holdings in Clorox by 1,715.5% during the 2nd quarter. Van ECK Associates Corp now owns 1,461,207 shares of the company’s stock valued at $199,411,000 after purchasing an additional 1,380,724 shares during the last quarter. Nuance Investments LLC lifted its holdings in Clorox by 150.6% during the 2nd quarter. Nuance Investments LLC now owns 1,597,674 shares of the company’s stock valued at $218,035,000 after purchasing an additional 960,094 shares during the last quarter. Wulff Hansen & CO. lifted its holdings in Clorox by 13,547.0% during the 2nd quarter. Wulff Hansen & CO. now owns 440,116 shares of the company’s stock valued at $60,063,000 after purchasing an additional 436,891 shares during the last quarter. Finally, International Assets Investment Management LLC lifted its holdings in Clorox by 424.9% during the 3rd quarter. International Assets Investment Management LLC now owns 538,576 shares of the company’s stock valued at $877,390,000 after purchasing an additional 435,971 shares during the last quarter. 78.53% of the stock is owned by institutional investors.

Clorox Price Performance

Shares of CLX opened at $169.06 on Friday. The firm has a market capitalization of $20.93 billion, a PE ratio of 58.91, a PEG ratio of 3.11 and a beta of 0.41. The company’s 50-day moving average is $162.72 and its 200-day moving average is $148.22. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $169.21. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating the consensus estimate of $1.36 by $0.50. The company had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 4.78% and a return on equity of 316.08%. The company’s revenue was up 27.0% on a year-over-year basis. During the same period in the prior year, the firm earned $0.49 earnings per share. Equities analysts forecast that The Clorox Company will post 6.85 EPS for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 2.89%. The ex-dividend date is Wednesday, January 29th. Clorox’s payout ratio is presently 170.03%.

Insider Activity

In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the transaction, the executive vice president now directly owns 13,471 shares in the company, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 0.57% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. Evercore ISI cut their price target on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Citigroup boosted their price target on shares of Clorox from $165.00 to $170.00 and gave the stock a “neutral” rating in a research note on Friday, September 6th. JPMorgan Chase & Co. boosted their price objective on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a report on Friday, October 11th. Barclays boosted their price objective on shares of Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a report on Friday, November 1st. Finally, BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Five research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and a consensus target price of $155.00.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.